Prolacta Bioscience recognizes nurses caring for fragile infants every day throughout Neonatal Nurses Week and NICU Awareness Month
Type: Press Releases
Topic(s): Company
Black, Hispanic, Asian babies born very early are less likely to receive lifesaving measures
Type: Prolacta in the News
Topic(s): 22-27 weeks (extremely premature) Clinical Studies Feeding Protocols Growth Healthcare Professionals
Prolacta Bioscience celebrated Breastfeeding Awareness Month by recognizing the commitment of NICU parents to their infants’ health
Type: Press Releases
Topic(s): Company Parents
Prolacta Bioscience Appoints Dr. Erin Hamilton Spence as Director of Clinical Education and Professional Development
Type: Press Releases
Topic(s): Company
Multiple peer-reviewed studies show Prolacta’s 100% human milk-based nutritional fortifiers reduce risk of life-threatening comorbidities in premature infants, compared to cow milk-based nutrition
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies Clinical Studies on Prolact/Humavant CR Company Growth Late-Onset Sepsis Necrotizing Entercolitis (NEC) Retinopathy of Prematurity (ROP)
Could human breast milk balance your gut microbiome?
Type: Prolacta in the News
Topic(s): Company Microbiome Probiotics
Prolacta Bioscience introduces its first evidence-based feeding protocol for an exclusive human milk diet in the NICU
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD) Company Early Fortification Feeding Intolerance Feeding Protocols Growth Healthcare Professionals Late-Onset Sepsis Length of hospital stay Long-Term outcomes Necrotizing Entercolitis (NEC) Product Retinopathy of Prematurity (ROP)
Prolacta Bioscience appoints David Steinberg as chief financial officer
Type: Press Releases
Topic(s): Company
International Conference on Human Milk Science & Innovation to discuss latest research on bioactivity and neurodevelopment
Type: Press Releases
Topic(s): Clinical Studies Conferences and Events Neurodevelopmental Outcomes Probiotics
